A detailed history of Stratos Wealth Partners, Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 172,888 shares of MRK stock, worth $17 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
172,888
Previous 160,803 7.52%
Holding current value
$17 Million
Previous $19.9 Million 1.38%
% of portfolio
0.29%
Previous 0.32%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$111.15 - $128.97 $1.34 Million - $1.56 Million
12,085 Added 7.52%
172,888 $19.6 Million
Q2 2024

Jul 24, 2024

SELL
$123.8 - $132.96 $240,048 - $257,809
-1,939 Reduced 1.19%
160,803 $19.9 Million
Q1 2024

Apr 16, 2024

SELL
$113.24 - $131.95 $213,230 - $248,461
-1,883 Reduced 1.14%
162,742 $21.5 Million
Q4 2023

Jan 24, 2024

SELL
$100.18 - $109.02 $1.11 Million - $1.21 Million
-11,091 Reduced 6.31%
164,625 $17.9 Million
Q3 2023

Oct 24, 2023

BUY
$102.95 - $114.33 $317,703 - $352,822
3,086 Added 1.79%
175,716 $18.1 Million
Q2 2023

Jul 18, 2023

BUY
$108.61 - $118.38 $1.31 Million - $1.43 Million
12,102 Added 7.54%
172,630 $19.9 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $407,539 - $454,730
-3,959 Reduced 2.41%
160,528 $17.1 Million
Q4 2022

Jan 19, 2023

BUY
$87.44 - $112.11 $571,245 - $732,414
6,533 Added 4.14%
164,487 $0
Q3 2022

Oct 24, 2022

BUY
$84.53 - $94.96 $296,277 - $332,834
3,505 Added 2.27%
157,954 $13.6 Million
Q2 2022

Jul 22, 2022

BUY
$83.49 - $94.64 $973,827 - $1.1 Million
11,664 Added 8.17%
154,449 $14.1 Million
Q1 2022

Apr 26, 2022

BUY
$73.51 - $82.4 $154,371 - $173,040
2,100 Added 1.49%
142,785 $11.7 Million
Q4 2021

Jan 14, 2022

BUY
$72.28 - $90.54 $1.04 Million - $1.31 Million
14,435 Added 11.43%
140,685 $10.8 Million
Q3 2021

Oct 19, 2021

BUY
$71.68 - $78.83 $2.66 Million - $2.92 Million
37,067 Added 41.56%
126,250 $9.48 Million
Q2 2021

Jul 19, 2021

SELL
$70.31 - $77.77 $66,091 - $73,103
-940 Reduced 1.04%
89,183 $6.94 Million
Q1 2021

Apr 27, 2021

BUY
$68.86 - $81.11 $400,420 - $471,654
5,815 Added 6.9%
90,123 $6.95 Million
Q4 2020

Jan 29, 2021

SELL
$71.77 - $79.65 $74,569 - $82,756
-1,039 Reduced 1.22%
84,308 $6.9 Million
Q3 2020

Oct 29, 2020

BUY
$73.18 - $82.95 $276,839 - $313,799
3,783 Added 4.64%
85,347 $7.08 Million
Q2 2020

Jul 28, 2020

BUY
$70.42 - $80.13 $337,523 - $384,063
4,793 Added 6.24%
81,564 $6.31 Million
Q1 2020

May 04, 2020

BUY
$63.36 - $87.82 $487,745 - $676,038
7,698 Added 11.14%
76,771 $5.91 Million
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $49,961 - $56,375
644 Added 0.94%
69,073 $6.28 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $5.16 Million - $5.62 Million
67,805 Added 10866.19%
68,429 $5.76 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $5.22 Million - $5.69 Million
-68,558 Reduced 99.1%
624 $8.26 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $227,329 - $265,575
3,255 Added 4.94%
69,182 $5.8 Million
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $745,897 - $850,739
10,720 Added 19.42%
65,927 $5.48 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $12,265 - $14,233
-188 Reduced 0.34%
55,207 $4.22 Million
Q3 2018

Nov 02, 2018

SELL
$57.69 - $67.84 $364,716 - $428,884
-6,322 Reduced 10.24%
55,395 $3.93 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $386,968 - $454,648
-7,613 Reduced 10.98%
61,717 $3.75 Million
Q1 2018

May 10, 2018

BUY
$50.96 - $59.23 $389,283 - $452,457
7,639 Added 12.38%
69,330 $3.78 Million
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $71,080 - $84,878
-1,377 Reduced 2.18%
61,691 $3.47 Million
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $3.7 Million - $3.98 Million
63,068
63,068 $4.04 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.